[PDF][PDF] COVID-19, a clinical syndrome manifesting as hypersensitivity pneumonitis

YG Song, HS Shin - Infection & chemotherapy, 2020 - synapse.koreamed.org
Acute HP is more common in the elderly. The defective innate immunity and the accelerated
complement activation induced by SARS-CoV-2, similar to that by SARS CoV, leads to a …

[HTML][HTML] A pathophysiological perspective on COVID-19's lethal complication: from viremia to hypersensitivity pneumonitis-like immune dysregulation

MA Sanchez-Gonzalez, D Moskowitz… - Infection & …, 2020 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the coronavirus
responsible for our recent coronavirus disease 2019 pandemic, is driving a lung …

[HTML][HTML] Hyperinflammation with COVID-19: the key to patient deterioration?

K Haigh, ZJ Syrimi, S Irvine, TJ Blanchard… - Clinical Infection in …, 2020 - Elsevier
Background The potential risk of cytokine storm in patients with coronavirus disease 2019
(COVID-19) has been described [1]; we write to share our experience treating a 17-year-old …

Cytokine storm in severe COVID‐19 pneumonia

B Gürsoy, CD Sürmeli, M Alkan, C Satıcı… - Journal of Medical …, 2021 - Wiley Online Library
In this study, laboratorial parameters of hospitalized novel coronavirus (COVID‐19) patients,
who were complicated with severe pneumonia, were compared with the findings of cytokine …

[HTML][HTML] Fatal superimposed bacterial sepsis in a healthy coronavirus (COVID-19) patient

M Jose, K Desai - Cureus, 2020 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) is a highly infectious disease caused by the
newly discovered coronavirus, SARS-CoV-2 (severe acute respiratory syndrome …

[HTML][HTML] Immunostimulation with interferon‐γ in protracted SARS‐CoV‐2 pneumonia

AC Lukaszewicz, F Venet, A Faure… - Journal of Medical …, 2021 - ncbi.nlm.nih.gov
Dear Editor, We read with great interest the recent publication describing two coronavirus
disease 2019 (COVID‐19) patients with protracted severe acute respiratory syndrome …

[HTML][HTML] COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management

M Russano, F Citarella, A Napolitano… - Expert opinion on …, 2020 - Taylor & Francis
Introduction The COVID-19 pandemic occurred amid the cancer immunotherapy revolution.
Immune checkpoint inhibitors (ICIs) have become the standard of care for several solid …

[HTML][HTML] Covid‐19: time for a paradigm change

FM Buonaguro, PA Ascierto, GD Morse… - Reviews in medical …, 2020 - ncbi.nlm.nih.gov
As of May 11, 2020, coronavirus disease 2019 (Covid-19) has been confirmed in 4 152 670
people worldwide, carrying a mortality of approximately 6.8%, 1 compared with a mortality …

[HTML][HTML] Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient

Y Nakajima, A Ogai, K Furukawa, R Arai, R Anan… - Journal of Infection and …, 2021 - Elsevier
The duration of viral shedding of SARS-CoV-2 is usually less than 10 days. We experienced
a COVID-19 case with prolonged viral shedding for 2 months. His cell mediated immunity …

[HTML][HTML] Severe pneumonia with co-infection of H5N1 and SARS-CoV-2: a case report

K Jin, Z Dai, P Shi, Y Li, C Zhu - BMC Infectious Diseases, 2024 - Springer
Abstract Background The H5N1 influenza virus is a cause of severe pneumonia. Co-
infection of influenza virus and severe acute respiratory syndrome coronavirus 2 (SARS …